BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26447820)

  • 1. Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Hashad DI; Elyamany AS; Salem PE
    Genet Test Mol Biomarkers; 2015 Nov; 19(11):604-9. PubMed ID: 26447820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
    Nomair AM; Kandil LS; Nomeir HM; Kandil NS
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
    J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
    Zheng Y; Hlady RA; Joyce BT; Robertson KD; He C; Nannini DR; Kibbe WA; Achenbach CJ; Murphy RL; Roberts LR; Hou L
    Clin Epigenetics; 2019 Oct; 11(1):145. PubMed ID: 31639042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.
    Hassouna MM; Naguib M; Radwan EM; Abdel-Samiee M; Estaphan S; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3357-3363. PubMed ID: 33247696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
    Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
    J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M
    Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of thrombogenic genes polymorphisms with hepatocellular carcinoma in HCV Egyptian patients.
    Hanafy AS; Alaa FA; Randa MH
    Gene; 2016 Apr; 580(1):37-40. PubMed ID: 26768578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma.
    Couvert P; Carrié A; Tezenas du Montcel S; Vaysse J; Sutton A; Barget N; Trinchet JC; Beaugrand M; Ganne N; Giral P; Chelly J
    Clin Res Hepatol Gastroenterol; 2012 Aug; 36(4):345-51. PubMed ID: 22902352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
    Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
    Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.